ArticlePharmaceutical research2021

Targeted Delivery of Combination Therapeutics Using Monoclonal Antibody 2C5-Modified Immunoliposomes for Cancer Therapy.

Radhika Narayanaswamy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.